About
Basic Data Updated:
11 days agoBafna Pharmaceuticals Limited is known for its tablet manufacturing facility located in Madhavaram, Chennai, as stated in its credit rating report. Additionally, the company has also expanded its operations to include capsule and oral syrup facilities. In 2001, a new unit was established by the company to produce beta-lactam products. Over the years, Bafna has primarily focused on supplying pharmaceutical products to institutions and the generic market. However, it has also made significant progress in registering its products in the international market. In order to further expand its manufacturing capabilities, the company recently inaugurated its second facility in Grantylon, Tamil Nadu. Furthermore, Bafna has also established a research and development unit at the Grantylon facility, ... Read More
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Website1222442
- Telephone1222442
- Email Address1222442
Financials of Bafna Pharmaceuticals Limited
Enhance accessibility to Bafna Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Bafna Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Bafna Pharmaceuticals Limited
Unlock and access historical data on people associated with Bafna Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
MB
Mahaveer Bafna
CEOStatus: Current
VK
Vishnu Kuppa Company SecretaryStatus: Current
MS
Melagiri Sridhar CFOStatus: Current
Board Members(7)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Feb 2024 | ₹12.00 Cr | Open |
Others Creation Date: 30 Nov 2023 | ₹12.00 Cr | Open |
Others Creation Date: 05 Jun 2023 | ₹2.00 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bafna Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bafna Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Hvcs Corporate Solutions Private Limited
Active
8 years 4 months Sundaresan Palamadai is a mutual person
Sai Wardha Power Generation Private Limited
Active 18 years 6 months Akila Raju and Upendar Reddy are mutual person
Ramanagaram Enterprises Private Limited
Active 22 years 2 months Akila Raju and Upendar Reddy are mutual person
Recent activity within the organization
Charges
A charge with Others amounted to Rs. 12.00 cr with Charge ID 100870424 was registered on 21 Feb 2024.
21 Feb 2024Charges
A charge with Others of Rs. 2.00 cr registered on 05 Jun 2023 with Charge ID 100742729 was modified on 13 Dec 2023.
13 Dec 2023Charges
A charge with Others amounted to Rs. 12.00 cr with Charge ID 100879610 was registered on 30 Nov 2023.
30 Nov 2023Annual General Meeting
Bafna Pharmaceuticals Limited last Annual general meeting of members was held on 22 Sep 2023 as per latest MCA records.
22 Sep 2023Director Appointment
Krishna Yeachuri was appointed as a Director was appointed as a Director on 26 Jun 2023 & has been associated with this company since 10 months 4 days .
26 Jun 2023
Recent News, Updates & Announcement
NCLAT restricts handing over of Bafna Pharma to its promoter.Business Standard 11 Mar 2019
- Bafna Pharmaceuticals appoints Company Secretary ampamp CO.
The Board of Directors in their meeting held on November 10 2017 has appointed Ms Nirmala L as the Company Secretary and Compliance Officer of the Company with effect from October 23 2017.
Moneycontrol 10 Nov 2017
Frequently asked questions
What is the Incorporation or founding date of Bafna Pharmaceuticals Limited?
